Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- The Discovery of Protein Phosphorylation
-
1. Phosphorylase and the origin of reversible protein phosphorylation
- Prof. Edmond Fischer
- Protein Kinase Cascades
- The Modulation of Protein Function by Phosphorylation
-
4. Two is the key to 14-3-3: dimeric mechanical signaling devices
- Prof. Carol MacKintosh
- Protein Phosphatases
-
5. Structure and mechanisms of protein phosphatases
- Prof. David Barford
-
6. Protein tyrosine phosphatases
- Prof. Jack Dixon
-
7. The regulation of MAP kinase signalling by dual-specificity protein phosphatases
- Prof. Steve M. Keyse
- The Structures of Protein Kinases
-
9. Protein kinase structure, function and regulation
- Prof. Susan Taylor
-
10. The structural basis for the modulation of protein function by protein phosphorylation
- Prof. Dame Louise N. Johnson
- Biological Systems that are Regulated by Reversible Phosphorylation
-
11. Protein phosphorylation and the control of protein synthesis
- Prof. Christopher Proud
-
13. Roles of AMPK in energy homeostasis and nutrient sensing
- Prof. Grahame Hardie
-
14. Serine kinases and T lymphocyte biology
- Prof. Doreen Cantrell
-
15. The interplay between protein phosphorylation and ubiquitylation in the NF-κB pathway
- Prof. Zhijian 'James' Chen
-
16. SMAD phosphorylation and the TGF-beta pathway
- Prof. Joan Massagué
- Protein Kinases and Human Disease
-
17. Function and regulation of the PDK1 kinase
- Prof. Dario Alessi
-
18. LKB1 pathway and its role in cancer
- Prof. Dario Alessi
-
19. WNK1 pathway and its role in regulating hypertension
- Prof. Dario Alessi
-
20. The hyperphosphorylation of tau and Alzheimer's disease
- Prof. Michel Goedert
- Protein Kinases as Targets for the Development of Anti-Cancer Drugs
-
21. PI3K/AKT signaling in cancer
- Prof. Neal Rosen
-
22. RAS and RAF signaling in melanoma: biology and therapies
- Prof. Richard Marais
-
23. The mTOR kinase as a target for anti-cancer drugs
- Prof. David Sabatini
- Archived Lectures *These may not cover the latest advances in the field
-
25. AMP-activated protein kinase: regulating cellular and whole body energy balance
- Prof. Grahame Hardie
Printable Handouts
Navigable Slide Index
- Introduction
- Ubiquitination vs. phosphorylation (1)
- Ubiquitination vs. phosphorylation (2)
- Ubiquitination vs. phosphorylation (3)
- Ubiquitin-binding domains
- Ubiquitination vs. phosphorylation (4)
- Ubiquitin signaling in the NF-kappaB pathway
- NF-kappaB signaling pathway
- The biochemical pathway of IkB ubiquitination (1)
- The biochemical pathway of IkB ubiquitination (2)
- The IL-1R/toll-like receptor pathway
- TRAF-6, Nemo-dependent IKK activation in vitro
- Activation of IKK by TRAF6 requires two factors
- TRAF6-regulated IKK activator-2
- Ubc13 is required for IKK activation by IL-1beta
- Catalytic activity of Ubc13
- TRIKA1 = Ubc13/Uev1A
- Domain organization of TRAFs
- TRAF6 is a ubiquitin ligase
- Polyubiquitin chains
- K63-linked polyUb chains mediate IKK activation
- Human ubiquitin genes
- An inducible ubiquitin "knock-in" system
- K63 is required for IKK activation by IL-1beta
- TRIKA2 = TAK1/TAB1/TAB2
- Ubiquitin activation of stress kinases
- The proposed model
- The CYLD and NEMO pathologies
- Innate and adaptive immunity
- Acknowledgement
Topics Covered
- Ubiquitination is a reversible covalent modification, akin to phosphorylation
- Ubiquitination regulates protein kinase activity through proteasome-independent mechanisms
- K63-linked polyubiquitination activates TAK1 and IKK in the NF-kappaB pathway
- Deubiquitination enzymes inhibit protein kinases in the NF-kappaB pathway
- Protein kinase regulation by ubiquitin is important in innate and adaptive immunity
Talk Citation
Chen, Z.'. (2010, November 30). The interplay between protein phosphorylation and ubiquitylation in the NF-κB pathway [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved January 15, 2025, from https://doi.org/10.69645/PGQM8626.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Zhijian 'James' Chen has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
The interplay between protein phosphorylation and ubiquitylation in the NF-κB pathway
Published on November 30, 2010
30 min
A selection of talks on Cell Biology
Hide